市場調査レポート

商品コード

1498628

バイオ分析検査サービスの市場規模、シェア、成長分析、分子別、検査別、ワークフロー別、用途別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Molecule, By Test, By Workflow, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年06月10日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 822,189円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 961,806円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,101,423円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.13円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオ分析検査サービスの市場規模は、2022年に24億2,000万米ドルとなり、予測期間（2024～2031年）のCAGRは15%で、2023年の27億8,000万米ドルから、2031年までには85億1,000万米ドルに成長する見通しです。

バイオ分析検査サービス市場には、医薬品や生物製剤のヒトにおける安全性と有効性を評価するために製薬企業やバイオテクノロジー企業に提供される分析サービスが含まれます。これらのサービスには、血液、尿、組織などの生体液や組織中の薬剤、代謝物、バイオマーカー濃度の測定が含まれ、医薬品開発や規制当局の承認に不可欠です。例えば、WuXi AppTecは、生物学的分析自動化をいち早く採用し、生産性を400%向上させました。市場はCROやその他のサービスプロバイダーで構成され、医薬品開発をサポートするために効率的で正確な検査を提供することを目指しています。新薬の開発と承認の必要性が成長の促進力ですが、高コストと標準化された方法の欠如が大きな課題となっています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Eurofins Scientific SE（Luxembourg）
Charles River Laboratories International, Inc.（US）
Laboratory Corporation of America Holdings（US）
WuXi AppTec（China）
PPD, Inc.（US）
Frontage Laboratories, Inc.（US）
SGS SA（Switzerland）
ICON plc（Ireland）
Intertek Group plc（UK）
Bioanalytical Systems, Inc.（US）
Almac Group（UK）
Anapharm（Canada）
Pharmaron Beijing Co., Ltd.（China）
Syneos Health（US）
Celerion（US）
BioAgilytix Labs（US）
Medpace Holdings, Inc.（US）
Bioclinica（US）
LGC Limited（UK）
PSI CRO AG（Switzerland）

Product Code: SQMIG35D2157

Bioanalytical Testing Services Market size was valued at USD 2.42 Billion in 2022 and is poised to grow from USD 2.78 Billion in 2023 to USD 8.51 Billion by 2031, at a CAGR of 15 % during the forecast period (2024-2031).

The bioanalytical testing services market encompasses analytical services provided to pharmaceutical and biotech companies to assess the safety and efficacy of drugs and biologics in humans. These services, which include measuring drug, metabolite, and biomarker concentrations in biological fluids and tissues such as blood, urine, and tissue, are crucial for drug development and regulatory approval. For example, WuXi AppTec's early adoption of bioanalytical automation led to a 400% productivity increase. The market consists of CROs and other service providers, aiming to deliver efficient and accurate testing to support drug development. Growth is driven by the need for new drug development and approval, but high costs and lack of standardized methods pose significant challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioanalytical Testing Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioanalytical Testing Services Market Segmental Analysis

Bioanalytical Testing Services Market is segmented based on Molecule, Test, Workflow, Application, End User and region. By molecule, the market is segmented into small molecules and large molecules. By test, the market is segmented into ADME, Pharmacokinetics, Pharmacodynamics, Bioavailability, Bioequivalence, and Others. By Workflow, the market is segmented into Sample Preparation (Protein Precipitation, Liquid-Liquid Extraction, Solid Phase Extraction), Sample Analysis (Hyphenated technique, Chromatographic technique, Electrophoresis, Ligand Binding Assay, Mass Spectrometry, Nuclear Magnetic Resonance). By application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, and others. By end users, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Bioanalytical Testing Services Market

The increasing demand for personalized medicines is significantly boosting the bioanalytical testing services sector, which is crucial for developing and testing these tailored treatments. Bioanalytical testing is essential in assessing drug efficacy for individual patients, ensuring the selection of the most suitable treatment plans. For example, the global surge in cancer cases has driven the need for self-administered, forward-looking drugs, making this a highly profitable market. This focus on personalized cancer therapies has, in turn, accelerated the growth of the bioanalytical testing market by improving the effectiveness of cancer treatments through more precise and patient-specific drug evaluation.

Restraints in the Bioanalytical Testing Services Market

The bioanalytical testing market faces significant growth constraints due to a shortage of skilled personnel capable of managing advanced equipment requirements. This challenge is underscored by the projected 13% increase in demand for medical laboratory technicians between 2016 and 2026, highlighting a critical gap in workforce supply. Without sufficient skilled technicians, the adoption of new technologies and processes may be hindered, thereby limiting market expansion. As the industry evolves, this shortfall in expertise could pose substantial barriers, restricting the ability to fully leverage technological advancements and meet the growing needs of the bioanalytical testing sector.

Market Trends of the Bioanalytical Testing Services Market

Pharmaceutical companies are increasingly turning to third-party service providers for bioanalytical testing to cut costs, boost efficiency, and concentrate on their primary areas of expertise. This outsourcing trend is anticipated to grow in the foreseeable future. By partnering with specialized external firms, pharmaceutical companies can leverage advanced technologies and expert knowledge without the burden of maintaining extensive in-house laboratories. This strategic shift allows them to streamline operations, enhance productivity, and allocate more resources to drug development and innovation, thereby accelerating time-to-market for new therapies and responding more swiftly to evolving industry demands and regulatory requirements.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Patent Analysis
Pricing Analysis
Ecosystem of the Market
Start-up Analysis
Case Study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Bioanalytical Testing Service Market by Molecule

Small Molecule
Large Molecule
- Liquid Chromatography-Mass (LC-MS) Spectrometry
- Immunoassays
- Pharmacokinetics (PK)
- Anti-Drug Antibodies (ADA)
- Others
Others

Bioanalytical Testing Service Market by Test Type

Market Overview
ADME
- In-Vivo
- In-Vitro
Pharmacokinetic (PK)
Pharmacodynamics (PD)
Bioavailability
Bioequivalence
Other

Bioanalytical Testing Service Market by Workflow

Market Overview
Sample Preparation
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
Other Workflow

Bioanalytical Testing Service Market by Application

Market Overview
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Applications

Bioanalytical Testing Service Market by End User

Market Overview
Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMO)
Contract Research Organizations (CRO)

Bioanalytical Testing Service Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioanalytical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anapharm (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron Beijing Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioclinica (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PSI CRO AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

バイオ分析検査サービスの市場規模、シェア、成長分析、分子別、検査別、ワークフロー別、用途別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Molecule, By Test, By Workflow, By Application, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

バイオ分析検査サービス市場：分子別

バイオ分析検査サービス市場：検査タイプ別

バイオ分析検査サービス市場：ワークフロー別

バイオ分析検査サービス市場：用途別

バイオ分析検査サービス市場：エンドユーザー別

バイオ分析検査サービス市場規模：地域別